Skin regeneration company PolarityTE reveals SEC investigation, probing into its lead product, former CFO and current investors
Days after publishing in a medical journal a positive case study showcasing its technology that employs a patient’s own healthy tissue to regenerate human skin for the treatment of burns and wounds, PolarityTE has come under fire after it divulged it had been subpoenaed by the SEC earlier this month.
PolarityTE executed a reverse merger with video game publisher Majesco known for the cult classic Psychonauts, to get onto the market in 2017. The biotech was founded by Denver Lough — a surgeon who specializes in regenerative medicine and reconstructive surgery, who took over as CEO from outgoing chief Barry Honig post-merger.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.